Home/Filings/4/0001562180-23-006237
4//SEC Filing

Greene Barry E 4

Accession 0001562180-23-006237

CIK 0001597553other

Filed

Aug 7, 8:00 PM ET

Accepted

Aug 8, 4:15 PM ET

Size

7.5 KB

Accession

0001562180-23-006237

Insider Transaction Report

Form 4
Period: 2023-08-04
Greene Barry E
DirectorPresident and CEO
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-08-04+195,000195,000 total
    Exercise: $85.82Exp: 2031-01-04Common Stock (195,000 underlying)
Footnotes (1)
  • [F1]On January 4, 2021, the reporting person was granted an option to purchase 650,000 shares of common stock. The option vests upon the achievement of certain milestones, one of which was met on August 4, 2023, resulting in the vesting of the option as to 195,000 shares.

Issuer

Sage Therapeutics, Inc.

CIK 0001597553

Entity typeother

Related Parties

1
  • filerCIK 0001291963

Filing Metadata

Form type
4
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 4:15 PM ET
Size
7.5 KB